This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero

.

Loading

Management & Treatment of VTE Patients – Practical advice for Pharmacists

14 May 2022
Clinical

 

 

 

 

 

 

This session has been fully organised and funded by Bayer and contains promotional content. Adverse event reporting and prescribing information is available at the end of the presentation. 

This presentation will provide an overview from a pharmacist’s perspective of the practicalities of managing patients with venous thromboembolism (VTE), in line with current national guidelines. With a focus on anticoagulation in VTE, the clinical evidence for the use of DOACs for the management of acute VTE and prevention of VTE recurrence will be examined along with the considerations surrounding extended anticoagulation in at-risk patients and the management of cancer-associated thrombosis (CAT).

RP-XAR-GB-4123, March 2022

 

Speakers
Anthony Hackett, Senior VTE Lead Pharmacist - St Thomas’ Hospital, London

Partners

Lead Education Partner

  • CPPE
  • Morph

 

Education Partner

  • APTUK
  • BOPA
  • BPNG
  • CMHP
  • Health Education England

 

Education Partner

  • HIVPA
  • UKRPG
  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC

 

Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS

 

Education Partner

  • Soar Beyond
  • NHCA
  • UKBPA
  • UKCPA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS

 

Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber

 

Nominated Charity

  • Pharmacist Support

 

Newsletter Sign Up